Having trouble accessing articles? Reset your cache.

Oct. 10 Preclinical Quick Takes: Merck-Prokaryotics Inc.-Princeton ID new antibiotic class; plus NIH, Owkin, Genentech and ICR

Merck, Prokaryotics, Princeton ID new class of antibiotic
Merck & Co. Inc. (NYSE:MRK), Prokaryotics Inc. and Princeton University researchers reported in a Proceedings of the National Academy of Sciences paper the identification of MRL-494, a small molecule representing a new antibiotics class that acts against Gram-negative and Gram-positive

Read the full 478 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE